Your browser doesn't support javascript.
loading
Seroprevalence of group B Coxsackieviruses: Retrospective study in an Italian population.
Sciandra, Ilaria; Falasca, Francesca; Maida, Paola; Tranquilli, Giulia; Di Carlo, Daniele; Mazzuti, Laura; Melengu, Taulant; Giannelli, Gianluigi; Antonelli, Guido; Turriziani, Ombretta.
Afiliação
  • Sciandra I; National Institute of Gastroenterology "S. de Bellis", Research Hospital, Castellana Grotte, Italy.
  • Falasca F; Virology Unit, Department of Molecular Medicine, Sapienza University, Rome, Italy.
  • Maida P; Infectious Diseases Unit, Department of Public Health and Infectious Disease, Sapienza University, Rome, Italy.
  • Tranquilli G; Virology Unit, Department of Molecular Medicine, Sapienza University, Rome, Italy.
  • Di Carlo D; Virology Unit, Department of Molecular Medicine, Sapienza University, Rome, Italy.
  • Mazzuti L; Virology Unit, Department of Molecular Medicine, Sapienza University, Rome, Italy.
  • Melengu T; Virology Unit, Department of Molecular Medicine, Sapienza University, Rome, Italy.
  • Giannelli G; National Institute of Gastroenterology "S. de Bellis", Research Hospital, Castellana Grotte, Italy.
  • Antonelli G; Virology Unit, Department of Molecular Medicine, Sapienza University, Rome, Italy.
  • Turriziani O; Virology Unit, Department of Molecular Medicine, Sapienza University, Rome, Italy.
J Med Virol ; 92(12): 3138-3143, 2020 Dec.
Article em En | MEDLINE | ID: mdl-32531866
ABSTRACT
Group B Coxsackieviruses (CVB) include six serotypes (B1-6) responsible for a wide range of clinical diseases. Since no recent seroepidemiologic data are available in Italy, the study aim was to investigate CVB seroprevalence in a wide Italian population. The study retrospectively included 2459 subjects referring to a large academic hospital in Rome (Italy) in the period 2004-2016. Seroprevalence rates and neutralizing antibodies (nAb) titers were evaluated in relation to years of observation and subjects' characteristics. Positivity for at least one serotype was detected in 69.1% of individuals. Overall, the prevalent serotype was B4, followed by B3 (33.3%), B5 (26.2%), B1 (12.7%), B2 (11.0%), and B6 (1.7%). For B2, a significant decrease in seroprevalence over years was observed. Positivity to at least one virus was 25.2% in children aged 0 to 2 years, but significantly increased in preschool (3-5 years) (50.3%) and school (6-10 years) children (70.4%). Higher nAb responses for B3 and B4 were observed in children aged 3 to 5 years. A high overall CVB prevalence was found. Type-specific variations in prevalence over time probably reflect the fluctuations in circulation typical of Enteroviruses. Children are at greater risk for CVB infection given the high number of seronegative subjects aged 0 to 10 years.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Risk_factors_studies Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Risk_factors_studies Idioma: En Ano de publicação: 2020 Tipo de documento: Article